Flossbach Von Storch’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-29,923
Closed -$954K 105
2017
Q2
$954K Sell
29,923
-14,018
-32% -$442K 0.01% 88
2017
Q1
$1.43M Buy
43,941
+9,486
+28% +$299K 0.02% 83
2016
Q4
$1.06M Buy
+34,455
New +$1.05M 0.02% 90
2016
Q2
Sell
-1,197,797
Closed -$33.7M 96
2016
Q1
$33.7M Buy
1,197,797
+10,540
+0.9% +$301K 0.54% 27
2015
Q4
$36.4M Sell
1,187,257
-940,137
-44% -$29.6M 0.62% 30
2015
Q3
$63.4M Buy
2,127,394
+86,976
+4% +$2.79M 1.1% 22
2015
Q2
$64.9M Sell
2,040,418
-80,999
-4% -$2.64M 1.25% 22
2015
Q1
$70M Sell
2,121,417
-189,373
-8% -$6.02M 1.58% 19
2014
Q4
$68.3M Sell
2,310,790
-141,531
-6% -$4.06M 1.6% 20
2014
Q3
$68.8M Buy
2,452,321
+302,372
+14% +$8.49M 1.49% 24
2014
Q2
$60.5M Buy
2,149,949
+94,259
+5% +$2.69M 1.45% 25
2014
Q1
$62.6M Sell
2,055,690
-2,557,847
-55% -$76.3M 1.67% 20
2013
Q4
$134M Sell
4,613,537
-227,770
-5% -$6.63M 3.81% 8
2013
Q3
$132M Buy
4,841,307
+84,141
+2% +$2.29M 4.05% 9
2013
Q2
$126M Buy
+4,757,166
New +$131M 3.82% 13

Other funds holding PFE

Flossbach Von Storch's PFE Position: Q3 2017 in Review

Flossbach Von Storch sold out of Pfizer (PFE) in Q3 2017, closing a stake of 29,923 shares — an estimated $954K sold.

Flossbach Von Storch first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $134M in Q4 2013. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Flossbach Von Storch reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Flossbach Von Storch sold 29,923 Pfizer shares in Q3 2017, an estimated $954K.
  • Flossbach Von Storch first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
  • Flossbach Von Storch's Pfizer position peaked at $134M in Q4 2013.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Flossbach Von Storch's 13F filing for Q3 2017, filed 9 Nov 2017.